Table 5.
Comparison of metabolic and exercise testing characteristics in patients before and after the exercise
| Items | CT group (n = 20) | IT group (n = 22) | ||
|---|---|---|---|---|
| Pre‐treatment | Post‐treatment | Pre‐treatment | Post‐treatment | |
| FBG (mmol/L) | 7.00 ± 0.50 | 6.35 ± 0.75* | 6.91 ± 1.04 | 5.88 ± 0.66**‡ |
| PBG (mmol/L) | 13.03 ± 1.37 | 9.37 ± 0.91** | 12.82 ± 3.74 | 8.69 ± 2.50** |
| FIN (μU/mL) | 11.77 ± 5.63 | 11.34 ± 3.94 | 12.81 ± 10.16 | 8.30 ± 4.41* |
| PIN (μU/mL) | 91.11 ± 40.33 | 62.01 ± 36.9** | 103.39 ± 87.20 | 78.46 ± 62.57** |
| HbA1c (%) | 6.91 ± 0.62 | 6.16 ± 0.48** | 6.50 ± 0.96 | 5.64 ± 0.47** |
| TG (mmol/L) | 2.65 ± 1.18 | 2.56 ± 0.92 | 2.40 ± 1.47 | 1.79 ± 0.98 |
| TC (mmol/L) | 4.47 ± 1.04 | 4.31 ± 1.05 | 5.50 ± 1.20 | 4.88 ± 1.17* |
| LDL‐c (mmol/L) | 3.22 ± 1.18 | 3.03 ± 0.67 | 3.60 ± 1.06 | 2.86 ± 1.08** |
| ET (min) | 6.93 ± 1.38 | 6.90 ± 1.87 | 6.70 ± 1.43 | 7.20 ± 1.55 |
| Max HR (b.p.m.) | 132.7 ± 12.84 | 136.0 ± 20.61 | 142.45 ± 13.98 | 135.00 ± 11.17* |
| Max Mets (mets) | 6.73 ± 1.53 | 6.96 ± 1.40 | 7.07 ± 1.86 | 8.88 ± 1.68**† |
| HRR (b.p.m.) | 12.90 ± 5.71 | 15.75 ± 6.30* | 14.00 ± 3.47 | 19.77 ± 5.08**† |
| RHR (b.p.m.) | 87.90 ± 7.29 | 82.20 ± 6.16* | 86.59 ± 11.81 | 77.95 ± 5.32**† |
Values represent means ± standard deviation. Compared with the pre‐treatment group *P < 0.05, **P < 0.01; compared with the conventional‐therapy group, † P < 0.05, ‡ P < 0.01. ET, exercise time; FPG, fasting glucose; FPI, fasting insulin; PPG, postprandial glucose (2‐h); Hba1c, glycosylated hemoglobin; HRR, heart rate recovery; LDL‐c, low‐density lipoprotein cholesterol; Max HR, maximum heart rate; Max Mets, maximal metabolic equivalents; PPI, postprandial insulin (2‐h); RHR, resting heart rate; TC, total cholesterol; TG, triglycerides.